92 related articles for article (PubMed ID: 7508055)
1. Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study.
Senior R; Imbs JL; Bory M; Amabile G; Denis B; Zannad F; De Luca N; Marchegiano R; Lahiri A; Raftery EB
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S106-10. PubMed ID: 7508055
[TBL] [Abstract][Full Text] [Related]
2. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study.
Gosse P; Sheridan DJ; Zannad F; Dubourg O; Guéret P; Karpov Y; de Leeuw PW; Palma-Gamiz JL; Pessina A; Motz W; Degaute JP; Chastang C
J Hypertens; 2000 Oct; 18(10):1465-75. PubMed ID: 11057435
[TBL] [Abstract][Full Text] [Related]
3. Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis.
Roush GC; Abdelfattah R; Song S; Ernst ME; Sica DA; Kostis JB
J Clin Hypertens (Greenwich); 2018 Oct; 20(10):1507-1515. PubMed ID: 30251403
[TBL] [Abstract][Full Text] [Related]
4. Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide.
Curry CL; Robinson H; Brown R; Olivan J; Sami M; Honos G; Ruddy TD; Balazovjech I; Touzek F; Galinier F; Mariani M; de Cordoüe A; Barrandon S; Brault Y; Guez D
Am J Hypertens; 1996 Aug; 9(8):828-32. PubMed ID: 8862231
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design.
Gosse P; Dubourg O; Guéret P; De Simone G; Schmieder R; De Leeuw PW; Degaute JP; García Puig J; Karpov Y; Magometschnigg D; Matos L; Amouyel P; Asmar R; Le Heuzey JY; Nieminen M; Dahlöf B
J Hum Hypertens; 2002 Sep; 16(9):653-9. PubMed ID: 12214263
[TBL] [Abstract][Full Text] [Related]
6. Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients.
Agabiti-Rosei E; Zulli R; Muiesan ML; Salvetti M; Rizzoni D; Corbellini C; Monteduro C
Blood Press; 1998 May; 7(3):160-9. PubMed ID: 9758086
[TBL] [Abstract][Full Text] [Related]
7. Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients.
Okin PM; Hille DA; Kjeldsen SE; Lindholm LH; Edelman JM; Dahlöf B; Devereux RB
Am J Hypertens; 2010 Jul; 23(7):786-93. PubMed ID: 20395941
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy.
Asmar R; Garcia-Puig J; Gosse P; Karpov YA; De Leeuws PW; Magometschniggs D; Matos L; Schmieder R
Vasc Health Risk Manag; 2007; 3(4):371-80. PubMed ID: 17969366
[TBL] [Abstract][Full Text] [Related]
9. Effects of delapril in combination with indapamide on blood pressure and left ventricular mass in elderly hypertensive patients.
Acanfora D; Lowenthal DT; Furgi G; Trojano L; Picone C; Nicolino A; Iannuzzi GL; Papa A; Rengo F
Am J Ther; 1998 Jan; 5(1):17-23. PubMed ID: 10099033
[TBL] [Abstract][Full Text] [Related]
10. Regression of left ventricular hypertrophy in previously untreated essential hypertension: different effects of enalapril and hydrochlorothiazide.
Dahlöf B; Hansson L
J Hypertens; 1992 Dec; 10(12):1513-24. PubMed ID: 1338083
[TBL] [Abstract][Full Text] [Related]
11. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study.
Dahlöf B; Gosse P; Guéret P; Dubourg O; de Simone G; Schmieder R; Karpov Y; García-Puig J; Matos L; De Leeuw PW; Degaute JP; Magometschnigg D;
J Hypertens; 2005 Nov; 23(11):2063-70. PubMed ID: 16208150
[TBL] [Abstract][Full Text] [Related]
12. [Arterial stiffness, wave reflections and myocardial protection: the REASON project].
London GM
Drugs; 2003; 63 Spec No 1():9-17. PubMed ID: 12708879
[TBL] [Abstract][Full Text] [Related]
13. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
15. [Management of hypertensive patients with left ventricular hypertrophy].
Ambrosioni E
Presse Med; 2002 Oct; 31 Spec No 2():S13-6. PubMed ID: 12355999
[TBL] [Abstract][Full Text] [Related]
16. [The effectiveness and tolerability of losartan and effect on left ventricular mass in patients with essential hypertension].
Tedesco MA; Ratti G; Aquino D; Caccavale A; Acitorio M; Rocereto A; Cosimi R; Coppolino P; Iarussi D; Iacono A
Cardiologia; 1998 Jan; 43(1):53-9. PubMed ID: 9534293
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular hypertrophy regression: the LIVE trial.
Sheridan DJ
Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):541-3. PubMed ID: 12497780
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophy.
Thürmann PA
J Cardiovasc Pharmacol; 1999; 33 Suppl 1():S33-6; discussion S41-3. PubMed ID: 10028952
[TBL] [Abstract][Full Text] [Related]
19. Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH.
Novo S; Abrignani MG; Novo G; Nardi E; Dominguez LJ; Strano A; Barbagallo M
Am J Hypertens; 2001 Jul; 14(7 Pt 1):637-43. PubMed ID: 11465647
[TBL] [Abstract][Full Text] [Related]
20. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects.
de Luca N; Asmar RG; London GM; O'Rourke MF; Safar ME;
J Hypertens; 2004 Aug; 22(8):1623-30. PubMed ID: 15257187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
